| 1 |
EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS
Lloyd Paul Aiello, Alexander J. Brucker, Stanley Chang et al. · Retina
|
Oct 2004 |
413 |
| 2 |
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
Richard Alan Furie, Gastón P. León, Meenu Thomas et al. · Annals of the Rheumatic Diseases
|
20 Apr 2014 |
170 |
| 3 |
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
Joan T. Merrill, William R Shanahan, Morton Aaron Scheinberg et al. · Annals of the Rheumatic Diseases
Open access |
Jun 2018 |
161 |
| 4 |
Fomivirsen
Richard S. Geary, Scott P. Henry, Lisa R. Grillone · Clinical Pharmacokinetics
|
2002 |
159 |
| 5 |
Characterization of pulmonary function in Duchenne Muscular Dystrophy
Oscar Henry Mayer, Richard S. Finkel, Christian Rummey et al. · Pediatric Pulmonology
Open access |
9 Mar 2015 |
156 |
| 6 |
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial
Robert S. Rosenson, Colin Hislop, Daniel S McConnell et al. · The Lancet
|
Feb 2009 |
114 |
| 7 |
Tachykinins activate guinea‐pig alveolar macrophages: involvement of NK2 and NK1 receptors
Sandra Brunelleschi, L. Vanni, Fabrizio Ledda et al. · British Journal of Pharmacology
Open access |
Jul 1990 |
107 |
| 8 |
Effects of Varespladib Methyl on Biomarkers and Major Cardiovascular Events in Acute Coronary Syndrome Patients
Robert S. Rosenson, Colin Hislop, Michael D. Elliott et al. · Journal of the American College of Cardiology
Open access |
Sep 2010 |
100 |
| 9 |
Bromfenac Ophthalmic Solution 0.09% (Xibrom) for Postoperative Ocular Pain and Inflammation
Eric D. Donnenfeld, Edward J. Holland, Robert H. Stewart et al. · Ophthalmology
|
20 Apr 2007 |
88 |
| 10 |
Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE− / − Mice
Heather I. Fraser, Colin Hislop, Robert Christie et al. · Journal of Cardiovascular Pharmacology
|
2009 |
88 |
| 11 |
Further evidence for the existence of NK2 tachykinin receptor subtypes
Riccardo Patacchini, Mara Astolfi, Laura Quartara et al. · British Journal of Pharmacology
Open access |
Sep 1991 |
77 |
| 12 |
A Norrin/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathy
Rony Chidiac, Md. Joynal Abedin, Graham Dickson and Hugh MacLeod et al. · EMBO Molecular Medicine
Open access |
9 Jun 2021 |
74 |
| 13 |
Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease
Robert S. Rosenson, Michael D. Elliott, Yuri Stasiv et al. · European Heart Journal
|
16 Nov 2010 |
67 |
| 14 |
Potent contractile activity of endothelin on the human isolated urinary bladder
Carlo Alberto Maggi, Sandro Giuliani, Riccardo Patacchini et al. · British Journal of Pharmacology
Open access |
Apr 1989 |
66 |
| 15 |
The synergistic inhibition of atherogenesis in apoE−/− mice between pravastatin and the sPLA2 inhibitor varespladib (A-002)
Zory Shaposhnik, Xuping Wang, Joaquim Trias et al. · Journal of Lipid Research
Open access |
22 Nov 2008 |
64 |
| 16 |
Multiple sources of calcium for contraction of the human urinary bladder muscle
Carlo Alberto Maggi, Sandro Giuliani, Riccardo Patacchini et al. · British Journal of Pharmacology
Open access |
Nov 1989 |
54 |
| 17 |
Effect of calpain and proteasome inhibition on Ca 2+ ‐dependent proteolysis and muscle histopathology in the mdx mouse
Alexandre Briguet, Michael A. Erb, I. Courdier-Fruh et al. · The FASEB Journal
|
26 Aug 2008 |
53 |
| 18 |
Lorcaserin for Smoking Cessation and Associated Weight Gain: A Randomized 12-Week Clinical Trial
William R Shanahan, Jed E. Rose, Alan Glicklich et al. · Nicotine & Tobacco Research
|
2 Nov 2016 |
51 |
| 19 |
Barriers to drug adherence in the treatment of urea cycle disorders: Assessment of patient, caregiver and provider perspectives
Oleg A. Shchelochkov, Klara Dickinson, Bruce F. Scharschmidt et al. · Molecular Genetics and Metabolism Reports
Open access |
21 Jul 2016 |
49 |
| 20 |
The presence of mucosa reduces the contractile response of the guinea-pig urinary bladder to substance P
Carlo Alberto Maggi, Paolo Santicioli, Massimo Parlani et al. · Journal of Pharmacy and Pharmacology
|
Aug 1987 |
49 |
| 21 |
Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children
Mark B. Abelson, Gail L. Torkildsen, Jon I. Williams et al. · Clinical Therapeutics
|
Sep 2009 |
48 |
| 22 |
Inhibition of Secretory Phospholipase A2 in Patients with Acute Coronary Syndromes: Rationale and Design of the Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks (VISTA-16) Trial
Stephen James Nicholls, Matthew Aaron Cavender, John J.P. Kastelein et al. · Cardiovascular Drugs and Therapy
Open access |
23 Nov 2011 |
45 |
| 23 |
A-002 (Varespladib), a phospholipase A2inhibitor, reduces atherosclerosis in guinea pigs
José Oyama Moura Leite, Ushma Vaishnav, Michael J. Puglisi et al. · BMC Cardiovascular Disorders
Open access |
17 Feb 2009 |
42 |
| 24 |
Outcomes After Metal-on-metal Hip Revision Surgery Depend on the Reason for Failure: A Propensity Score-matched Study
Gulraj S. Matharu, Andrew Judge, David W. Murray et al. · Clinical Orthopaedics and Related Research
Open access |
17 Jan 2018 |
40 |
| 25 |
Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod
Michelle Petri, Renée S. Martin, Morton Aaron Scheinberg et al. · Lupus
|
28 Jun 2016 |
40 |
| 26 |
Influence of peripherally-administered peptides on ethanol-induced gastric ulcers in the rat
Stefano Evangelista, Carlo Alberto Maggi, Alberto Meli · General Pharmacology The Vascular System
|
1987 |
38 |
| 27 |
Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate
Jon I. Williams, James A. Gow, Sharon M. Klier et al. · Current Medical Research and Opinion
|
25 Aug 2010 |
34 |
| 28 |
Pupil dilatation in response to vagal afferent electrical stimulation is mediated by inhibition of parasympathetic outflow in the rat
Ralph Bianca, Barry R. Komisaruk · Brain Research
|
14 Aug 2007 |
34 |
| 29 |
Safety and Efficacy of Bromfenac Ophthalmic Solution (Bromday) Dosed Once Daily for Postoperative Ocular Inflammation and Pain
Bonnie An Henderson, Johnny L. Gayton, Simon P. Chandler et al. · Ophthalmology
|
23 Jul 2011 |
33 |
| 30 |
Varespladib Inhibits Secretory Phospholipase A2 in Bronchoalveolar Lavage of Different Types of Neonatal Lung Injury
Danièle De Luca, Angelo Minucci, Joaquim Trias et al. · The Journal of Clinical Pharmacology
|
21 May 2011 |
33 |
| 31 |
The reversed binding of β-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitors
Sonja Nordhoff, Silvia Cerezo-Gálvez, Achim Feurer et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
12 Jan 2006 |
32 |
| 32 |
Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain
Steven Silverstein, Melissa G. Cable, Ehsan Sadri et al. · Current Medical Research and Opinion
|
14 Jul 2011 |
29 |
| 33 |
An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine
Judy Caron, Randall E. Kaye, Thomas C. Wessel et al. · Journal of Clinical Pharmacy and Therapeutics
Open access |
10 May 2020 |
27 |
| 34 |
GABAA receptor‐mediated positive inotropism in guinea‐pig isolated left atria: evidence for the involvement of capsaicin‐sensitive nerves
Carlo Alberto Maggi, Sandro Giuliani, Stefano Manzini et al. · British Journal of Pharmacology
Open access |
May 1989 |
26 |
| 35 |
Varespladib methyl in cardiovascular disease
Robert S. Rosenson, Heather I. Fraser, Joaquim Trias et al. · Expert Opinion on Investigational Drugs
|
Sep 2010 |
22 |
| 36 |
Burden of Friedreich’s Ataxia to the Patients and Healthcare Systems in the United States and Canada
Barbara Polek, Mary Jo Roach, William T. Andrews et al. · Frontiers in Pharmacology
Open access |
2013 |
21 |
| 37 |
Protective effects of Fe-Aox29, a novel antioxidant derived from a molecular combination of Idebenone and vitamin E, in immortalized fibroblasts and fibroblasts from patients with Friedreich Ataxia
Matthias L. Jauslin, Silvia Vertuani, Elisa Durini et al. · Molecular and Cellular Biochemistry
|
2 May 2007 |
21 |
| 38 |
Effect of lorcaserin on glycemic parameters in patients with type 2 diabetes mellitus
Faidon Magkos, Elena Nikonova, Randi Fain et al. · Obesity
Open access |
27 Mar 2017 |
18 |
| 39 |
Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials
Sandesh C.S. Nagamani et al. · Molecular Genetics and Metabolism
Open access |
6 Aug 2015 |
18 |
| 40 |
Anti-Inflammatory Effects of Varespladib Methyl in Diabetic Patients with Acute Coronary Syndrome
Robert S. Rosenson, Heather I. Fraser, Michael A. Goulder et al. · Cardiovascular Drugs and Therapy
|
11 Oct 2011 |
18 |
| 41 |
Do Trabecular Metal Acetabular Components Reduce the Risk of Rerevision After Revision THA Performed for Periprosthetic Joint Infection? A Study Using the NJR Data Set
Gulraj S. Matharu, Andrew Judge, David W. Murray et al. · Clinical Orthopaedics and Related Research
Open access |
12 Nov 2018 |
17 |
| 42 |
Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser
Morton Aaron Scheinberg, Colin Hislop, Renée S. Martin · Expert Opinion on Biological Therapy
|
7 Apr 2016 |
17 |
| 43 |
Health Care Transition Experiences of Males with Childhood-onset Duchenne and Becker Muscular Dystrophy: Findings from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) Health Care Transitions and Other Life Experiences Survey
Pangaja Paramsothy, Adrienne R. Herron, Molly M. Lamb et al. · PLoS Currents
Open access |
2018 |
15 |
| 44 |
Effects of lorcaserin on pre‐existing valvulopathy: A pooled analysis of phase 3 trials
Neil J. Weissman, Steven R. Smith, Randi Fain et al. · Obesity
Open access |
26 Nov 2016 |
14 |
| 45 |
Carbohydrate Restriction Reduces Lipids and Inflammation and Prevents Atherosclerosis in Guinea Pigs
Moises Torres‐Gonzalez, Jeff S. Volek, José Oyama Moura Leite et al. · Journal of Atherosclerosis and Thrombosis
Open access |
2008 |
12 |
| 46 |
RESUME-1: A Phase III Study of Tolperisone in the Treatment of Painful, Acute Muscle Spasms of the Back
Sanam Ara Vaughan, Kayla Torres, Randall E. Kaye · Pain Management
Open access |
Jul 2021 |
11 |
| 47 |
Predicting Response of Vitreous Hemorrhage after Intravitreous Injection of Highly Purified Ovine Hyaluronidase (Vitrase) in Patients with Diabetes
Abdhish R. Bhavsar, Lisa R. Grillone, Timothy R. McNamara et al. · Investigative Ophthalmology & Visual Science
|
Oct 2008 |
11 |
| 48 |
Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565)
Srinivas R. Nalamachu, Joseph V. Pergolizzi, Randall E. Kaye · Journal of Pain Research
Open access |
Nov 2020 |
10 |
| 49 |
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W. Konstan, Jeffrey S. Wagener, Michael A. Wilschanski et al. · Clinical Investigation
Open access |
2018 |
10 |
| 50 |
Role Attainment in Emerging Adulthood: Subjective Evaluation by Male Adolescents and Adults with Duchenne and Becker Muscular Dystrophy
Holly Landrum Peay, Barbara T. Do, Neil M. Khosla et al. · Journal of Neuromuscular Diseases
Open access |
5 Mar 2022 |
8 |